Accounts Payable - Portage Biotech Inc (NASDAQ:PRTG) - Alpha Spread

Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 10.21 USD 3.03% Market Closed
Market Cap: 214.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Portage Biotech Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Portage Biotech Inc
Accounts Payable Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Portage Biotech Inc
NASDAQ:PRTG
Accounts Payable
$1.5m
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
11%
Theratechnologies Inc
TSX:TH
Accounts Payable
$26.3m
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
17%
Repare Therapeutics Inc
NASDAQ:RPTX
Accounts Payable
$2.4m
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Accounts Payable
$8.4m
CAGR 3-Years
50%
CAGR 5-Years
4%
CAGR 10-Years
12%
Covalon Technologies Ltd
XTSX:COV
Accounts Payable
CA$3.8m
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
13%
Spectral Medical Inc
TSX:EDT
Accounts Payable
CA$2.8m
CAGR 3-Years
33%
CAGR 5-Years
43%
CAGR 10-Years
N/A

See Also

What is Portage Biotech Inc's Accounts Payable?
Accounts Payable
1.5m USD

Based on the financial report for Jun 30, 2024, Portage Biotech Inc's Accounts Payable amounts to 1.5m USD.

What is Portage Biotech Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
11%

Over the last year, the Accounts Payable growth was -43%. The average annual Accounts Payable growth rates for Portage Biotech Inc have been -2% over the past three years , 1% over the past five years , and 11% over the past ten years .

Back to Top